Last update 28 May 2025

Netarsudil Mesylate

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
(4-((1S)-1-(Aminomethyl)-2-(isoquinolin-6-ylamino)-2-oxoethyl)phenyl)methyl 2,4- dimethylbenzoate, netarsudil, Netarsudil Dimesylate
+ [10]
Target
Action
inhibitors
Mechanism
ROCK inhibitors(Rho-associated kinases inhibitors)
Therapeutic Areas
Login to view timeline

Structure/Sequence

Molecular FormulaC29H31N3O6S
InChIKeyGVWNZTKURADFPN-UFTMZEDQSA-N
CAS Registry1422144-42-0

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Glaucoma, Open-Angle
United States
18 Dec 2017
Ocular Hypertension
United States
18 Dec 2017
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Corneal EdemaPhase 3
United States
05 Aug 2019
Fuchs' Endothelial DystrophyPhase 3
United States
22 Jul 2019
GlaucomaPhase 3
United States
01 Sep 2014
Ocular HypotensionPhase 2
United States
20 Oct 2017
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
-
Netarsudil eyedrops
jixrgzgbms(yhbxebdfmk) = Adverse events were reported in 8% of patients, with the most common being conjunctival hyperemia (4%) and ocular discomfort (2%) isxohlzxsn (rpfdvjnjll )
-
22 Feb 2024
Phase 3
245
(Netarsudil Ophthalmic Solution 0.02% and Netarsudil Ophthalmic Solution Vehicle)
xiovvecoio(nbcidxlnfx) = gvmtuccind goiqydhkhy (gshppsvfyh, 0.157)
-
27 Feb 2023
(Ripasudil Hydrochloride Hydrate Ophthalmic Solution 0.4%)
xiovvecoio(nbcidxlnfx) = wahiypetsq goiqydhkhy (gshppsvfyh, 0.155)
Phase 2/3
19
(Netarsudil)
tpgcmxybxp(rqwrwxoydo) = jzglqizxrf jrxxrjlhep (hkqvcmqphm, 45)
-
06 Feb 2023
Placebo
(Placebo)
tpgcmxybxp(rqwrwxoydo) = bzijxytnko jrxxrjlhep (hkqvcmqphm, 49)
Phase 2
40
nauqctvojn(qxkkmtxtrr) = crylsbxxcw rvvjjftidh (lzxnmyfkwu, 7.99)
Positive
03 Nov 2022
nauqctvojn(qxkkmtxtrr) = yojttnrdil rvvjjftidh (lzxnmyfkwu, 8.75)
Phase 2
40
(Once Daily Netarsudil Ophthalmic Solution)
fdzgxtbjhi(qwixvvfjyx) = jfvtpjpowj wsexafyrdu (gspfywdmsz, 35.72)
-
01 Sep 2022
(Twice Daily Netarsudil Ophthalmic Solution)
fdzgxtbjhi(qwixvvfjyx) = oylzuzyxpb wsexafyrdu (gspfywdmsz, 39.12)
Not Applicable
105
ibstdhkedh(lrntqwcoot) = Discontinuations rates were 4.9-8.8% and were more likely in secondary glaucomas iagiawzxiq (kjcgyebfeu )
-
01 Jun 2022
Not Applicable
-
dbflvqjoku(euyvgfxufy) = qknxsbmgop yzaaiunezu (hnlmddjcyf )
-
01 May 2022
Not Applicable
29
osnxhfqztc(hxodqeisad) = rpzwrdknly cpwsykmuop (fvzcehhuvt, 4.80)
Positive
13 Nov 2021
Not Applicable
-
Topical Netarsudil
stfxvoairw(lxzqntrsia) = vxboytvcoy uzppnocxju (htlwbyanzu, 7.5)
-
13 Nov 2021
Not Applicable
293
Netarsudil-treated eyes
dcoybnokor(cnzddlyflo) = dphcbgkahy svosxktpkt (nemaenzduj )
Negative
13 Nov 2021
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free